Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig

Pain

Volumn 105, Issue 1-2, 2003, Pages 355-362

  Fox, Alyson ^a   Gentry, Clive ^a   Patel, Sadhana ^a   Kesingland, Adam ^a   Bevan, Stuart ^a  

^a Novatis Inst for Medical Sciences   (United Kingdom)

Author keywords

Neuropathic pain

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE;

ALLODYNIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG POTENCY; GUINEA PIG; HYPERALGESIA; MALE; NEUROPATHIC PAIN; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SCIATIC NERVE;

EID: 0141738662     PISSN: 03043959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3959(03)00253-7     Document Type: Article

References (44)

1. Backonja M. Anticonvulsants (antineuropathics) for neuropathic pain syndromes. Clin J Pain. 16:2000;S67-S72.
2. Backonja M., Beydoun A., Edwards K.R., Schwartz S.L., Fonseca V., Hes M., LaMoreaux L., Garofalo E. Gabapentin for the treatment of painful neuropathy in patients with diabetes mellitus. J Am Med Assoc. 280:1998;1831-1836.
3. Bennett G.J. Neuropathic pain. Wall P.D., Melzack R. Textbook of pain. 3rd ed. 1994;494-510 Churchill Livingstone, New York.
4. Bennett G.J., Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain. 33:1988;87-107.
5. Beydoun A., Kobetz S.A., Carrazana E.J. Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy. Clin J Pain. 2003;. in press.
6. Burchiel K.J. Carbamazepine inhibits spontaneous activity in experimental neuromas. Exp Neurol. 102:1988;249-253.
7. Campbell J.N. Nerve lesions and the generation of pain. Muscle Nerve. 24:2001;1261-1273.
8. Campbell E.A., Gentry C.G., Patel S., Panesar M.S., Walpole C.S.J., Urban L. Selective neurokinin-1 receptor antagonists are anti-hyperalgesic in a model of neuropathic pain in the guinea-pig. Neuroscience. 87:1998;527-532.
9. Cheung H., Kamp D., Harris E. An in vitro investigation of the action of lamotrigine on neuronal voltage-activated sodium channels. Epilepsy Res. 13:1992;107.
10. Christensen D., Gautron M., Guilbaud G., Kayser V. Effect of gabapentin and lamotrigine on mechanical allodynia-like behaviour in a rat model of trigeminal neuropathic pain. Pain. 93:2001;147-153.
11. Dreyer M., Edwards K., Norton J. Oxcarbazepine: preliminary experience in the treatment of neuropathic pain. J Pain. 3:2:(Suppl. 1):2002;39.
12. Field M.J., McCleary S., Hughes J., Singh L. Gabapentin and pregabalin, but not morphine and amitryptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain. 80:1999;391-398.
13. 1 receptors in the antihyperalgesic activity of cannabinoids in a model of neuropathic pain. Pain. 92:2001;91-100.
14. Hamza M., Rowlingson J. Initial experience with oxcarbazepine in the treatment of idiopathic neuropathic pain. J Pain. 3:2:(Suppl. 1):2002;40.
15. Han H.C., Lee D.H., Chung J.M. Characteristics of ectopic discharges in a rat neuropathic pain model. Pain. 50:1992;355-363.
16. Hao J.X., Urban L., Wiesenfeld-Hallin Z. Repeated administration of systemic gabapentin alleviates allodynia-like behaviors in spinally injured rats. Neurosci Lett. 280:2000;211-214.
17. Hunter J.C., Gogas K.R., Hedley L.R., Jacobsen L.O., Kassotakis L., Thompson J., Fontana D.J. The effect of novel anti-epileptic drugs in rat experimental models of acute and chronic pain. Eur J Pharmacol. 324:1997;153-160.
18. Ichikawa K., Koyama N., Kiguchi S., Kojima M., Yokata T. Inhibitory effect of oxcarbazepine on high-frequency firing in peripheral nerve fibres. Eur J Pharmacol. 420:2001;119-122.
19. Idanpaan-Heikkila J.J., Guilbaud G. Pharmacological studies on a rat model of trigeminal neuropathic pain: baclofen but not carbamazepine, morphine or tricyclic antidepressants attenuates the allodynia-like behaviour. Pain. 79:1999;281-290.
20. Kim S.O., Chung J.M. An experimental model for neuropathy produced by segmental spinal nerve ligation in the rat. Pain. 50:1992;355-363.
21. Luo Z.D., Calcutt N.A., Higuera E.S., Valder C.R., Song Y.H., Svensson C., Myers R.R. Injury type -specific calcium channel alpha-2 delta-l subunit upregulation in rat neuropathic pain models correlates with antiallodynic effects of gabapentin. J Pharmacol Exp Ther. 303:2002;1199-1205.
22. + channels. J Neurophysiol. 72:1994;349-359.
23. McQuay H., Carroll D., Jadad A., Wiffen P., Moore A. Anticonvulsant drugs for management of pain: a systematic review. Br Med J. 311:1995;1047-1052.
24. 2 and in the chronic hyperalgesia in rats with streptozotocin-induced diabetes. Pain. 33:1995;33-37.
25. Pan H.-L., Eisenach J.C., Chen S.-R. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther. 288:1999;1026-1030.
26. B agonists and gabapentin on mechanical hyperalgesia in models of neuropathic and inflammatory pain in the rat. Pain. 90:2001;217-226.
27. Rice ASC, Manton S, Postherpetic Neuralgia Study Group. Gabapentin in postherpetic neuralgia: a randomised, double blind, placebo controlled study. Pain 2001;94,215-224.
28. Rowbotham M., Harden N., Stacey B. Gabapentin for the treatment of postherpetic neuralgia. J Am Med Assoc. 280:1998;1837-1842.
29. Royal M., Jenson M., Bhakta B., Gunyea I., Mowa V., Ward S. An open-label trial of oxcarbazepine in patients with complex regional pain syndrome refractory to gabapentin. J Pain. 3:2:(Suppl. 1):2002;41.
30. Schmutz M., Brugger F., Gentsch C., McLean M.J., Olpe H.R. Oxcarbazepine: preclinical anticonvulsant profile and putative mechanisms of action. Epilepsia. 35:1994;S47-S50.
31. Seltzer Z., Dubner R., Shir Y. A novel behavioural model of neuropathic pain disorders produced in rats by partial sciatic nerve injury. Pain. 43:1990;205-218.
32. Sindrup S.H., Jensen T.S. Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action. Pain. 83:1999;389-400.
33. Taylor C.P., Gee N.S., Su T.-Z., Kocsis J.D., Welty D.F., Brown J.P., Dooley D.J., Boden P., Singh L. A summary of the mechanistic hypotheses of gabapentin pharmacology. Epilepsy Res. 29:1998;233-249.
34. Tecoma E.S. Oxcarbazepine. Epilepsia. 40:1999;S37-S46.
35. Teoh H., Fowler U., Bowery N.G. Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord. Neuropharmacology. 34:1995;1273-1278.
36. Tremont-Lukats I.W., Megeff C., Bakonja M.M. Anticonvulsants for neuropathic pain syndromes. Drugs. 60:2000;1029-1052.
37. Waldmeier P.C., Martin P., Stocklin K., Portet C., Schmutz M. Effect of carbamazepine, oxcarbazepine and lamotrigine on the increase in extracellular glutamate elicited by veratridine in rat cortex and striatum. Naunyn-Schmiedeberg Arch Pharmacol. 354:1996;164-172.
38. Wamil A.W., Schmutz M., Portet C., Feldmann K.F., McLean M.J. Effects of oxcarbazepine and 10-hydroxycarbamazepine on action potential firing and generalized seizures. Eur J Pharmacol. 271:1994;301-308.
39. Ward S., Royal M., Bhakta B., Gunyea I., Mowa V. An open-label trial of oxcarbazepine in patients with radiculopathy refractory to gabapentin. J Pain. 3:2:(Suppl. 1):2002;42.
40. White H.S. Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs. Epilepsia. 40:1999;S2-S10.
41. Wool C.J., Manion R.J. Neuropatic pain: aetiology, symptoms, mechanisms and management. Lancet. 353:1999;1959-1964.
42. + channels in rat hippocampal neurones. Pflugers Arch Eur J Physiol. 430:1995;437-446.
43. Zakrzewska J.M., Chaudry Z., Nurmikko T.J., Patton D.W., Mullens E.L. Lamotrigine (Lamictal) in refractory trigeminal neuralgia: results from a double-blind placebo controlled crossover trial. Pain. 73:1997;223-230.
44. Zakrzewska J.M., Patsalos P.N. Oxcarbazepine: a new drug in the management of intractable trigeminal neuralgia. J Neurol Neurosurg Psychiatry. 52:1989;472-476.